Lataa...
Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
Over the last few years, clinical trials with BRAF and mitogen-activated protein/extracellular signal-regulated kinase (MEK) inhibitors have shown significant clinical activity in melanoma, but only a fraction of patients respond to these therapies, and development of resistance is frequent. This ha...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4121406/ https://ncbi.nlm.nih.gov/pubmed/24920406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2014.2491 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|